Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

17%

1 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

Phase 1

2(33.3%)

Phase 2

2(33.3%)

N/A

1(16.7%)

Phase 3

1(16.7%)

6Total

Phase 1(2)

Phase 2(2)

N/A(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT03737461Phase 2Active Not Recruiting

Efficacy of Intradiscal Injection of BM-MSC in Subjects With Chronic Low Back Pain (LBP) Due to Lumbar Degenerative Disc Disease (DDD) Unresponsive

Role: collaborator

NCT03454737Not ApplicableUnknown

Treatment of Refractory Patellar Tendinopathy With Mesenquimal Trunk Cells. Comparative Study With PRP.

Role: lead

NCT03743155Phase 2Unknown

Clinical Trial to Evaluate the Effect and Safety of MSV in Xerostomy

Role: lead

NCT01227694Phase 1Completed

Adult Stem Cell Therapy for Repairing Articular Cartilage in Gonarthrosis

Role: collaborator

NCT01183728Phase 1Completed

Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells

Role: collaborator

NCT01440725Phase 3Completed

Efficacy of Platelet Rich Plasma for Treatment of Muscle Rupture With Haematoma

Role: lead

All 6 trials loaded